In breast cancer, tamoxifen induces the upregulation of TP53-induced glycolysis and apoptosis regulator (TIGAR), a p53 regulated gene that protects cancer cells against the onset of stress-induced mitochondrial dysfunction and aerobic glycolysis. Here, TP53 is linked to breast cancer.